These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27573604)

  • 1. Which place for ivabradine in Duchenne muscular dystrophy with heart failure?
    Fayssoil A
    Int J Cardiol; 2016 Nov; 223():768-769. PubMed ID: 27573604
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Ivabradine in dilated cardiomyopathy from Duchenne muscular dystrophy: A chance for slowing progression of heart failure?
    De Benedittis G; Della Rosa G; D'Ettorre E; Piscitelli P; Distante A; de Gregorio C
    Int J Cardiol; 2016 Nov; 223():286-288. PubMed ID: 27541675
    [No Abstract]   [Full Text] [Related]  

  • 3. Ivabradine: Role in the Chronic Heart Failure Armamentarium.
    Psotka MA; Teerlink JR
    Circulation; 2016 May; 133(21):2066-75. PubMed ID: 27217432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate reduction strategy using ivabradine in end-stage Duchenne cardiomyopathy.
    Adorisio R; Calvieri C; Cantarutti N; D'Amico A; Catteruccia M; Bertini E; Baban A; Filippelli S; Perri G; Amodeo A; Drago F
    Int J Cardiol; 2019 Apr; 280():99-103. PubMed ID: 30686494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivabradine (Corlanor) for heart failure.
    Med Lett Drugs Ther; 2015 May; 57(1469):75-6. PubMed ID: 25989196
    [No Abstract]   [Full Text] [Related]  

  • 6. Ivabradine in Management of Heart Failure: a Critical Appraisal.
    Orasanu G; Al-Kindi SG; Oliveira GH
    Curr Heart Fail Rep; 2016 Feb; 13(1):60-9. PubMed ID: 26797824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing heart rate with ivabradine in heart failure with reduced ejection fraction: Insights from a post-hoc analysis of the SHIFT trial.
    Joury A
    Eur J Heart Fail; 2023 Aug; 25(8):1436-1438. PubMed ID: 37370184
    [No Abstract]   [Full Text] [Related]  

  • 8. Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure.
    Cavusoglu Y; Mert U; Nadir A; Mutlu F; Morrad B; Ulus T
    J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):603-9. PubMed ID: 24922198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of ivabradine in dilated cardiomyopathy from Becker muscular dystrophy.
    Finsterer J; Stöllberger C; Berger E
    Herz; 2012 Sep; 37(6):702-5. PubMed ID: 22718185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Ivabradine on Inflammatory Markers in Chronic Heart Failure.
    Rohm I; Kretzschmar D; Pistulli R; Franz M; Schulze PC; Stumpf C; Yilmaz A
    J Immunol Res; 2016; 2016():6949320. PubMed ID: 27822484
    [No Abstract]   [Full Text] [Related]  

  • 11. Ivabradine approved for stable chronic heart failure.
    Traynor K
    Am J Health Syst Pharm; 2015 Jun; 72(11):896. PubMed ID: 25987676
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac and Hemodynamic Benefits: Mode of Action of Ivabradine in Heart Failure.
    Pereira-Barretto AC
    Adv Ther; 2015 Oct; 32(10):906-19. PubMed ID: 26521191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.
    Canet E; Lerebours G; Vilaine JP
    Ann N Y Acad Sci; 2011 Mar; 1222():90-9. PubMed ID: 21434947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use and Indication of Ivabradine in Heart Failure.
    Dodd K; Lampert BC
    Heart Fail Clin; 2018 Oct; 14(4):493-500. PubMed ID: 30266358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How does ivabradine effect erectile dysfunction in patients with heart failure?
    Aydın F; Bektur S; Taşdelen Y; Kıvrak Y; Hüseyinoglu Aydın A
    Kardiol Pol; 2017; 75(9):893-898. PubMed ID: 28541595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure.
    Deedwania P
    Drugs; 2013 Sep; 73(14):1569-86. PubMed ID: 24065301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
    Swedberg K; Komajda M; Böhm M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
    Lancet; 2010 Sep; 376(9744):875-85. PubMed ID: 20801500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivabradine: A Current Overview.
    Guha K; Allen CJ; Hartley A; Sharma R
    Curr Clin Pharmacol; 2016; 11(4):241-249. PubMed ID: 27784216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate and its reduction in chronic heart failure and beyond.
    Nikolovska Vukadinović A; Vukadinović D; Borer J; Cowie M; Komajda M; Lainscak M; Swedberg K; Böhm M
    Eur J Heart Fail; 2017 Oct; 19(10):1230-1241. PubMed ID: 28627045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
    Böhm M; Swedberg K; Komajda M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
    Lancet; 2010 Sep; 376(9744):886-94. PubMed ID: 20801495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.